Home
About
Services
Partners
Client Portfolio
News
Contact
Asian shares wobble amid trade, geopolitical tensions; focus on Fed meeting
June 17, 2019
Huawei says U.S. ban hurting more than expected, to wipe $30 billion off revenue
June 17, 2019
0
Pfizer to buy cancer drug developer Array for $10.64 billion
Published by
Muller&Green
at
June 17, 2019
Categories
RSS
Tags
Pfizer Inc said on Monday it would acquire Array Biopharma Inc for $10.64 billion in cash, giving it access to the target’s approved drugs for skin cancer and the targeted cancer medicines in its pipeline.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more